$38.11 0.20 (+0.53%)
2/13/2012 4:00 PM

Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar jtrax (< 20) Submitted: 8/4/2008 12:53:13 PM : Outperform Start Price: $28.14 MRK Score: +24.01

Merck is currently depressed in value and qualifies as a value purchase. It pays an excellent dividend and seems to have weathered the legal storms over Vytorin and Vioxx. A safe harbor in stormy times.

Report this Post Add Comment

Featured Broker Partners


Advertisement